FindTrial
Sign In

Study of anemia in children with nephrotic syndrome

Prevalence of Anemia in Children with Nephrotic syndrome: an observational cross sectional study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100941
Enrollment
75
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

Intervention1: Nil: Nil

Sponsors

Moti Lal Nehru Medical Collegeprayagraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of nephrotic syndrome aged 1-18 years presenting as- 1. Newly diagnosed cases 2. Relapse cases 3. Remission cases

Exclusion criteria

Exclusion criteria: 1. Patients with hemolytic anemia 2. Patients had/ were receiving iron supplements in last 3 months 3. Patients with chronic diseases such as congenital heart disease or chronic liver disease or chronic kidney disease

Design outcomes

Primary

MeasureTime frame
Prevalence of anemia in children with nephrotic syndrome at enrollmentTimepoint: To measure prevalence of anemia, it s severity and serum iron levels in children with nephrotic syndrome—

Secondary

MeasureTime frame
Severity of anemia in children with nephrotic syndrome Iron profile parameters in anemic patients Association of anemia with disease duration Association of anemia with relapse frequency Association of anemia with serum albumin levelsTimepoint: 1year—

Countries

India

Contacts

Public ContactProf Dr Anubha Shrivastava

Moti Lal Nehru Medical College,Prayagraj

snchalld2014@gmail.com09236804326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026